During the past decade, Leberstudienzentrum Kiel conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Leberstudienzentrum Kiel" are "Chronic Hepatitis C" (1 trials), "Hepatitis C" (1 trials) and "Non-Alcoholic Fatty Liver Disease" (1 trials). Many other conditions were trialed in "Leberstudienzentrum Kiel" in a lesser frequency.

Most popular intervention types in "Leberstudienzentrum Kiel" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "RBV" (2 trials), "SOF" (2 trials), "Peg-IFN" (1 trials), "Placebo to match RBV" (1 trials) and "Placebo to match SOF" (1 trials). Other intervention names were less common.

The vast majority of trials in "Leberstudienzentrum Kiel" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Leberstudienzentrum Kiel". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Leberstudienzentrum Kiel, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Leberstudienzentrum Kiel, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".